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Evaluation of a two-way, HIPAA-compliant text-messaging platform in a
health system specialty pharmacy

Health & Services

DJ Clark, PharmD; Adam Saulles, PharmD, CSP, BCACP; Tara Berkson, PharmD, BCACP

Background

Patients Who Transitioned from Phone Call
to Text-Based Refill Reminders (N=335)

Data Collection Period: February 2019 – March 2020
Study population: ≥18 years old with a diagnosis of MS
and ≥2 dispenses of disease-modifying medications
• Institutional Review Board-approved
• Single-center, retrospective analysis
• Data was collected via the electronic health record, the
implemented text messaging application, and
pharmacy phone system records.
• Outreach and medication refill date/time were collected
for the 5 (or total available if <5) most recent fills
before and after opt-in to the the text-messaging
platform.
• MPR was calculated based on dispense dates.
• Results are described using simple descriptive
statistics and T-tests, where applicable.

Patient Characteristics
Patients (N=515)
Average Age
51.8 years
Female
403 (78%)
Medication
Aubagio® (teriflunomide)
58 (11%)
Avonex® (interferon beta-1a)
64 (12%)
Betaseron® (interferon beta-1b)
4 (<1%)
Copaxone® (glatiramer acetate) 55 (11%)
Dalfampridine generic
12 (2%)
Gilenya® (fingolimod)
63 (12%)
Glatiramer acetate generic
60 (12%)
Glatopa® (glatiramer acetate)
3 (<1%)
Plegridy® (peginterferon beta-1a) 19 (4%)
Rebif® (interferon beta-1a)
25 (5%)
Tecfidera® (dimethyl fumarate)
153 (30%)
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Objectives

Methodology

All MS Patients by Outreach Type (N=515)
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To determine the impact of the implementation of a
HIPAA-compliant text-messaging platform on patient
adherence, engagement, and satisfaction

Labs on
admission:

Enrolled in Patient
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Primary Outcome: Time between pharmacy technician
outreach and medication refill
Secondary Outcomes:
• Medication possession ratio (MPR)
• Proportion of patients enrolled in the specialty
pharmacy’s patient management program
• Patient satisfaction assessed by in-application surveys
• Specialty pharmacy phone-call volume

Patient Enrollment Status:

Results

Hours

• Specialty medications represent a growing proportion of
prescription drug expenditures in the United States. In
2018, specialty medications represented 37.4% of
medication spending, but accounted for only 1.9% of
medication dispenses.1
• Increased utilization of specialty medications for
maintenance therapy is especially apparent in the
population of patients living with Multiple Sclerosis (MS).
• A 2017 study demonstrated that only ~50% of patients
with MS are adherent to prescribed regimens when
initiating disease-modifying therapy.2
• Prior to July 2019, the health system specialty pharmacy
only contacted MS patients via phone call to perform refill
coordination and pharmacist follow-up.
• In July 2019, a HIPAA-compliant messaging platform was
implemented. With this program, patients can respond to
refill inquiries at their convenience and provide typed
responses to medication-related safety, adherence, and
efficacy follow-up questions sent by specialty
pharmacists.
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358 (70%)
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Outcomes:
• Response to pharmacy caregiver outreach via textmessage was significantly faster than response to
traditional phone-call outreach overall.
• Patients who switched enrollment from phone-call
outreach to utilizing a text-message based platform
experienced a significant reduction in response time to
pharmacy outreach.
• Improved response time also translated into improved
overall medication adherence. Patients utilizing the textmessage based platform demonstrated a significantly
improved MPR.
• A 21% increase in the specialty pharmacy’s patient
management program enrollment was realized following
7.5 months of utilization of the implemented textmessaging platform. Enrollment in this management
program allows for comprehensive follow-up and
increased clinical monitoring by a specialty pharmacist.
• Satisfaction surveys reveal that enrolled patients are
highly satisfied with the implemented platform.
• Pharmacy phone-call volume did not change significantly
post-implementation of the text-messaging platform,
although this result may be confounded by the
consistently increasing prescription volume in the
specialty pharmacy. Furthermore, patients with MS
represent only ~10% of the population served by the
specialty pharmacy. Patients with many other disease
states continue to require phone call outreach. Future
expansion of the text-messaging option to additional
disease states is expected to reduce total pharmacy call
volume in the future.
Study Limitations:
• Only the five most recent dispenses were analyzed preand post-intervention.
• Results of satisfaction surveys may be subject to
selection bias. Patients who are comfortable utilizing the
text-messaging platform are more likely to respond to
satisfaction surveys submitted through the platform itself.

Conclusion
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The health system specialty pharmacy has utilized a
HIPAA-compliant text-messaging platform to successfully
improve patient response time, treatment adherence,
and overall engagement with clinical pharmacy services,
while delivering a positive patient experience.

Next Steps
These results will be pivotal in expanding use of a textmessaging platform to patients filling medications for
other conditions at the specialty pharmacy.
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